ASSET PURCHASE AGREEMENT by and among SANOFI and AASTROM BIOSCIENCES, INC. Dated as of April 19, 2014Asset Purchase Agreement • April 23rd, 2014 • Aastrom Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 23rd, 2014 Company Industry JurisdictionThis Asset Purchase Agreement is dated as of April 19, 2014 (the “Execution Date”), by and among Aastrom Biosciences, Inc., a Michigan corporation (“Purchaser”), and Sanofi, a French Société anonyme (“Seller”). Seller and its Affiliates that own Transferred Assets and/or are subject to Assumed Liabilities are collectively referred to in this Agreement as the “Selling Persons.” Purchaser and Seller are referred to in this Agreement each as a “Party” and collectively as the “Parties.”